Category: COVID-19 antigen test

Why Did the UK Government Waste £4 Billion on the Innova Lateral Flow Test?

Today is the first day of the multi-million pound COVID-19 Inquiry set up to “examine the UK’s response to and impact of the Covid-19 pandemic, and learn lessons for the future.” The irony is that one of the most important questions centered around the UK’s COVID-19 response will probably never be asked by the inquiry committee—why the…


Chinese Officials Profiteering From Overpriced COVID-19 Test Kits

Since the Omicron variant outbreak began in China, Chinese state-owned companies have been making billions of dollars selling test kits to the public. The rapid antigen detection tests approved by Chinese authorities for home use are selling at many times the cost of manufacturing. As the competition among Chinese manufacturers has intensified, the cost of…


Rapid Home COVID Antigen Tests May Have Severe Limitations

Commentary Many millions of these rapid antigen tests at a cost of billions of dollars are now in most homes. The federal government and many local organizations have been making them available without charge. But newly published research from the UK sheds a dark shadow on their usefulness. The initial hope was that making rapid…


British Company Pulls COVID-19 Testing Product Off Market Following Drop in Effectiveness

Britain’s Avacta Group has temporarily halted sales of its COVID-19 lateral flow test, according to a statement released Monday, in order to replace the antibody in the device and ensure that the effectiveness of detecting the Omicron variant is on par with that of previous strains. Avacta, based in Cambridge, has since lost a third…